New York, New York–(Newsfile Corp. – December 24, 2025) – Leading international securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital for potential violations of the federal securities laws after SEC probe is revealed. If you invested in Jefferies or Point Bonita, […]

New York, New York–(Newsfile Corp. – December 24, 2025) – Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations

New York, New York–(Newsfile Corp. – December 24, 2025) – Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential

New York, New York–(Newsfile Corp. – December 24, 2025) – Leading international securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BellRing Brands, Inc. (NYSE: BRBR) for potential violations of the federal securities laws. If you invested in BellRing, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/bellring-brands-inc-class-action-lawsuit. Why is BellRing

(NYSE MKT:MAIA), Purchases reflect strong confidence in the scientific differentiation and commercial potential of ateganosine CHICAGO, Dec. 24, 2025 (GLOBE NEWSWIRE) — MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that independent directors including Adelina Louie Ngar Yee and Stan V.

Centennial, Colorado–(Newsfile Corp. – December 24, 2025) – The Obesity Medicine Association (OMA) released its Position Statement on Medicare and Medicaid Coverage and Expanded Access to Obesity Medications, detailing the association’s recommendations and support for emerging federal policies expected to dramatically improve treatment access for millions of Americans living with obesity. The OMA commends the

MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings GlobeNewswire December 24, 2025 Purchases reflect strong confidence in the scientific differentiation and commercial potential of ateganosine CHICAGO, Dec. 24, 2025 (GLOBE NEWSWIRE) — MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer,

(NASDAQ:CRNC), BURLINGTON, Mass., Dec. 24, 2025 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that, in light of its current cash position and outlook for future cash generation, the Company entered into privately negotiated transactions with certain holders of its 1.50% Convertible Senior Notes

(CNSX:CQX),(OTC US:IMIMF),(Other OTC:IMIMF),(Boerse Frankfurt – Freiverkehr:3MX0),(CNSX:CQX.CN),(Boerse Frankfurt – Freiverkehr:3MX0.F), // Not for distribution to the United States newswire services or for dissemination in the United States // VANCOUVER, British Columbia, Dec. 24, 2025 (GLOBE NEWSWIRE) — Copper Quest Exploration Inc. (CSE: CQX; FRA: 3MX) (“Copper Quest” or the “Company“) is pleased to announce that, further

(NASDAQ:RR), Features enhanced functionality of industrial humanoid robot Dex, integrating compounding real-world data, simulation training and a robotics framework to drive productivity and efficiencies in Commercial & Industrial LAS VEGAS, Dec. 24, 2025 (GLOBE NEWSWIRE) — Richtech Robotics Inc. (Nasdaq: RR) (“Richtech Robotics” or the “Company”), a U.S.-based provider of AI-driven robots operating in commercial